You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy

Citation Tools

Article menu

Download PDFPDF

Endometrial cancer
2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Cucinella G, Schivardi G, Zhou XC, et al
2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy
International Journal of Gynecologic Cancer 2022;32:A132-A133.